These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6521517)

  • 1. [Primary fibrinolysis and adenocarcinoma of the prostate: presentation of 2 cases].
    López Jiménez L; Martín Martín F; Martín Jiménez T; Angel Rodríguez Marcos M; Montes Santiago J; Cuervas-Mons Martínez V; Moya Mir MS; Barbadillo García de Velasco R
    Med Clin (Barc); 1984 Nov; 83(15):637-9. PubMed ID: 6521517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute defibrination syndrome caused by prostatic adenocarcinoma].
    Kovács E; Petri B; Bajusz V
    Orv Hetil; 1969 Oct; 110(40):2346-7. PubMed ID: 5354129
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostatic meningeal carcinomatosis with low serum level of prostate-specific antigen.
    Honda M; Miyagawa I
    Urology; 2005 Dec; 66(6):1320. PubMed ID: 16360475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinolysis in prostate carcinomas of varying grades of differentiation with respect to estrogen therapy and castration].
    Oehler D; Feustel A
    Z Urol Nephrol; 1980 Mar; 73(3):201-10. PubMed ID: 7434984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.
    Hattab EM; Koch MO; Eble JN; Lin H; Cheng L
    J Urol; 2006 May; 175(5):1695-9; discussion 1699. PubMed ID: 16600733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of malignancy of prostate.
    Kapoor N; Surange S; Gupta KN; Husainy MA; Faizi M
    Indian J Pathol Microbiol; 2004 Apr; 47(2):186-8. PubMed ID: 16295464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A syndrome of hematological changes in cancer of the prostate gland].
    Rupniewska ZM; Czarkowska D; Miturzyńska-Stryjecka H
    Pol Tyg Lek; 1969 Dec; 24(48):1858-9. PubMed ID: 5212521
    [No Abstract]   [Full Text] [Related]  

  • 8. High dose hook effect in serum total and free prostate specific antigen in a patient with metastatic prostate cancer.
    Furuya Y; Cho S; Ohta S; Sato N; Kotake T; Masai M
    J Urol; 2001 Jul; 166(1):213. PubMed ID: 11435864
    [No Abstract]   [Full Text] [Related]  

  • 9. Skin metastasis of prostate adenocarcinoma to glans penis showing no correlation with serum prostate-specific antigen level.
    Kobashi-Katoh R; Tanioka M; Takahashi K; Miyachi Y
    J Dermatol; 2009 Feb; 36(2):106-8. PubMed ID: 19284456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diferelin treatment of primary local and generalized cancer of the prostate].
    Kolesnikov GP; Rusakov IG; Shaplygin LV; Voznesenskiĭ SA; Bystrov AA
    Urologiia; 2001; (6):17-9. PubMed ID: 11785073
    [No Abstract]   [Full Text] [Related]  

  • 11. Deoxythymidine kinase in the staging of prostatic adenocarcinoma.
    Letocha H; Eklöv S; Gronowitz S; Norlén BJ; Nilsson S
    Prostate; 1996 Jul; 29(1):15-9. PubMed ID: 8685050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimum prostate-specific antigen (PSA) level diagnostic of prostate cancer.
    Yesner R; Kelly LJ; Chan YK
    Conn Med; 1996 Jul; 60(7):399-404. PubMed ID: 8758658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced prostate cancer with normal serum prostate-specific antigen values.
    Cohen RJ; Haffejee Z; Steele GS; Nayler SJ
    Arch Pathol Lab Med; 1994 Nov; 118(11):1123-6. PubMed ID: 7526818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA measurement following prostatectomy: an unexpected error.
    Descotes JL; Legeais D; Gauchez AS; Long JA; Rambeaud JJ
    Anticancer Res; 2007; 27(2):1149-50. PubMed ID: 17465255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens.
    Rogatsch H; Moser P; Volgger H; Horninger W; Bartsch G; Mikuz G; Mairinger T
    Hum Pathol; 2000 Sep; 31(9):1102-7. PubMed ID: 11014578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: 7. Radiation therapy for localized disease.
    Warde P; Catton C; Gospodarowicz MK
    CMAJ; 1998 Dec; 159(11):1381-8. PubMed ID: 9861209
    [No Abstract]   [Full Text] [Related]  

  • 17. Incorrect biochemistry complicates prostate cancer management.
    McAuley I; Steinhoff G; McNeely M; Blood P
    Can J Urol; 2002 Apr; 9(2):1496-7. PubMed ID: 12010595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extremely high PSA (250ng/ml) in a patient with localised prostatic carcinoma.
    Colgan G; O'Brien MF; Ahmad I; Thornhill JA
    Ir Med J; 2005 Jan; 98(1):29. PubMed ID: 15782735
    [No Abstract]   [Full Text] [Related]  

  • 19. [Levels of cadmium, zinc, copper and selenium in subjects with diagnosed prostate cancer].
    Daragó A; Sapota A; Duda-Szymańska J
    Rocz Panstw Zakl Hig; 2003; 54 Suppl():39-40. PubMed ID: 12884501
    [No Abstract]   [Full Text] [Related]  

  • 20. A bleeding tongue - acute presentation of fibrinolysis.
    Hodson A; Hunt BJ
    Int J Lab Hematol; 2007 Oct; 29(5):393-4. PubMed ID: 17824923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.